Cationic glycolipids with cyclic and open galactose head groups for the selective targeting of genes to mouse liver
- 20 January 2009
- journal article
- Published by Elsevier in Biomaterials
- Vol. 30 (12) , 2369-2384
- https://doi.org/10.1016/j.biomaterials.2008.12.074
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Cationic liposomes as non‐viral carriers of gene medicines: Resolved issues, open questions, and future promisesMedicinal Research Reviews, 2006
- Imidazole groups on a linear, cyclodextrin-containing polycation produce enhanced gene delivery via multiple processesPublished by Elsevier ,2006
- Full deacylation of polyethylenimine dramatically boosts its gene delivery efficiency and specificity to mouse lungProceedings of the National Academy of Sciences, 2005
- LMO2 -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1Science, 2003
- Harmful potential of viral vectors fuels doubts over gene therapyNature, 2003
- In Vitro Gene Delivery by Degraded Polyamidoamine DendrimersBioconjugate Chemistry, 1996
- A Controlled Study of Adenoviral-Vector–Mediated Gene Transfer in the Nasal Epithelium of Patients with Cystic FibrosisNew England Journal of Medicine, 1995
- Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosisNature Genetics, 1994
- Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosisNature Genetics, 1994
- Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy.Proceedings of the National Academy of Sciences, 1994